Announced
Completed
Financials
Tags
Single Bidder
Domestic
laboratory
Completed
genetic testing
Friendly
United States
Majority
Private
Acquisition
Biotechnology
Synopsis
Exact Sciences, a provider of cancer screening and diagnostic tests, completed the acquisition of PreventionGenetics, a medical laboratory, for $190m. "PreventionGenetics is a natural fit with Exact Sciences, and we're thrilled to have their talented team join in our mission to make earlier cancer detection a routine part of medical care. We share in PreventionGenetics' belief that genetics can transform medicine, improve lives, and help eradicate cancer. With our deep relationships in primary care and PreventionGenetics' strong reputation among genetics specialists, Exact Sciences can help more people understand their inherited risk of cancer to catch it earlier and treat it more effectively," Kevin Conroy, Exact Sciences, Chairman and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.